T Yonei

Chemotherapy-induced neutropenia as a prognostic factor in advanced non-small-cell lung cancer: results from Japan Multinational Trial Organization LC00-03

Yusuke Kishida, Mutsuto Kawahara, Satoshi Teramukai et al. · British Journal of Cancer · 2009 · 88 citations · Full text

Medicine, Oncology, Pharmacology +14

Continued gefitinib treatment after disease stabilisation prolongs survival of Japanese patients with non-small-cell lung cancer: Okayama Lung Cancer Study Group experience

Katsuyuki Hotta, Keitaro Matsuo, Hiroshi Ueoka et al. · Annals of Oncology · 2005 · 29 citations

Medicine, Oncology, Pharmacotherapy +7

Second primary cancer in survivors following concurrent chemoradiation for locally advanced non-small-cell lung cancer

Nagio Takigawa, Katsuyuki Kiura, Yoshihiko Segawa et al. · British Journal of Cancer · 2006 · 27 citations · Full text

Medicine, Oncology, Radiation Oncology +15

Fractionated administration of irinotecan and cisplatin for treatment of lung cancer: a phase I study

Hiroshi Ueoka, Masahiro Tabata, Katsuyuki Kiura et al. · British Journal of Cancer · 1999 · 21 citations · Full text

Medicine, Oncology, Pharmacology +17

Interstitial lung disease (ILD) during gefitinib treatment in Japanese patients with non-small cell lung cancer (NSCLC): Okayama Lung Cancer Study Group

Kazushi Hotta, Shingo Harita, Akihiro Bessho et al. · Journal of Clinical Oncology · 2004 · 18 citations

Medicine, Oncology, Pharmacotherapy +13